Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds
2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg −1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg S-bromo-willardiine injected...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2002-05, Vol.444 (1), p.53-60 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 60 |
---|---|
container_issue | 1 |
container_start_page | 53 |
container_title | European journal of pharmacology |
container_volume | 444 |
creator | Menton, Kevin Spedding, Michael Gressens, Pierre Villa, Pascal Williamson, Toni Markham, Anthony |
description | 2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg
−1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg
S-bromo-willardiine injected into the cortex or white matter of 5-day-old mice pups. As the multiple effects of PIT may induce both beneficial and deleterious effects, a reanalysis of the structure–activity relationship was undertaken. PIT (50 μM) and 2,3′-pyridylisatogen were potent antagonists of responses to ATP in the taenia preparation of the guinea-pig caecum, but 2,3′-nitrophenylisatogen was not. The reactive immine oxide group could be substituted by a keto moiety (
N-(2′-pyridyl)phthalide) while maintaining antagonism of responses to ATP, equivalent to PIT. Thus, antagonism of P2Y receptors was not restricted to the isatogen nucleus. Other spin traps did not antagonise P2Y receptors, although dimethyl-pyrroline-
N-oxide (DMPO) increased the sensitivity of responses to ATP. Both
N-(2′-pyridyl)phthalide and 2,3′-nitrophenylisatogen was less neuroprotective than PIT (10 mg kg
−1, i.p.) in protecting against the
S-bromo-willardiine-induced lesions in mice, implying that both antagonism of P2Y receptors and the immine oxide moiety may be important for the neuroprotective effects of PIT. However, the usefulness of the neuroprotection was limited because, in motoneurones obtained from rat embryos, PIT (10–100 μM) exacerbated cell death. |
doi_str_mv | 10.1016/S0014-2999(02)01583-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72027431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299902015832</els_id><sourcerecordid>72027431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-e1d9b91eb1e90acb411b89e7dd157f3c87ce9372d711986d66fbee3de0a1edc33</originalsourceid><addsrcrecordid>eNqFkc2KFDEUhYMoTjv6CEo2ioKluUlXpbISGfyDAcWfhauQSm61kapKmaQGeufW1_GRfBJT3Y2zdHUv4Ts3h3MIuQ_sGTBonn9iDLYVV0o9ZvwJg7oVFb9BNtBKVTEJ_CbZ_EPOyJ2UvjPGasXr2-QMOKii4Bvy62MYkIaeptlPNEczl7mjZnL0A_9KI1qcc4jlIZtdmHwa6cp9QzrhEsMcQ0ab_RVS7PuypfUWf8r__Pxdzfvo3X7wyeSww6IKaT-YjIfrEdfVURvGOSyTS3fJrd4MCe-d5jn58vrV54u31eX7N-8uXl5WVijIFYJTnQLsABUzttsCdK1C6RzUshe2lRaVkNxJANU2rmn6DlE4ZAbQWSHOyaPj3eL9x4Ip69Eni8NgJgxL0pIzLrcCClgfQRtDShF7PUc_mrjXwPTagT50oNeANeP60IHmRffg9MHSjeiuVafQC_DwBJhkzdBHM1mfrrniXohGFu7FkcMSx5XHqJP1OFl0vvSStQv-P1b-Akfzp1s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72027431</pqid></control><display><type>article</type><title>Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Menton, Kevin ; Spedding, Michael ; Gressens, Pierre ; Villa, Pascal ; Williamson, Toni ; Markham, Anthony</creator><creatorcontrib>Menton, Kevin ; Spedding, Michael ; Gressens, Pierre ; Villa, Pascal ; Williamson, Toni ; Markham, Anthony</creatorcontrib><description>2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg
−1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg
S-bromo-willardiine injected into the cortex or white matter of 5-day-old mice pups. As the multiple effects of PIT may induce both beneficial and deleterious effects, a reanalysis of the structure–activity relationship was undertaken. PIT (50 μM) and 2,3′-pyridylisatogen were potent antagonists of responses to ATP in the taenia preparation of the guinea-pig caecum, but 2,3′-nitrophenylisatogen was not. The reactive immine oxide group could be substituted by a keto moiety (
N-(2′-pyridyl)phthalide) while maintaining antagonism of responses to ATP, equivalent to PIT. Thus, antagonism of P2Y receptors was not restricted to the isatogen nucleus. Other spin traps did not antagonise P2Y receptors, although dimethyl-pyrroline-
N-oxide (DMPO) increased the sensitivity of responses to ATP. Both
N-(2′-pyridyl)phthalide and 2,3′-nitrophenylisatogen was less neuroprotective than PIT (10 mg kg
−1, i.p.) in protecting against the
S-bromo-willardiine-induced lesions in mice, implying that both antagonism of P2Y receptors and the immine oxide moiety may be important for the neuroprotective effects of PIT. However, the usefulness of the neuroprotection was limited because, in motoneurones obtained from rat embryos, PIT (10–100 μM) exacerbated cell death.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(02)01583-2</identifier><identifier>PMID: 12191582</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>2,2′-Pyridylisatogen ; AMPA receptor ; Animals ; Animals, Newborn ; ATP antagonist ; Biological and medical sciences ; Dose-Response Relationship, Drug ; Female ; Guinea Pigs ; Immine oxide ; Isatin - analogs & derivatives ; Isatin - pharmacology ; Medical sciences ; Mice ; Motoneuron ; Motor Neurons - drug effects ; Muscle Contraction - drug effects ; Muscle, Smooth - drug effects ; Neuropharmacology ; Neuroprotection ; Neuroprotective agent ; Neuroprotective Agents - pharmacology ; P2Y receptor ; Pharmacology. Drug treatments ; Purinergic P2 Receptor Antagonists ; Spin trap ; Spin Trapping ; Structure-Activity Relationship</subject><ispartof>European journal of pharmacology, 2002-05, Vol.444 (1), p.53-60</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-e1d9b91eb1e90acb411b89e7dd157f3c87ce9372d711986d66fbee3de0a1edc33</citedby><cites>FETCH-LOGICAL-c391t-e1d9b91eb1e90acb411b89e7dd157f3c87ce9372d711986d66fbee3de0a1edc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0014-2999(02)01583-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13723367$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12191582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Menton, Kevin</creatorcontrib><creatorcontrib>Spedding, Michael</creatorcontrib><creatorcontrib>Gressens, Pierre</creatorcontrib><creatorcontrib>Villa, Pascal</creatorcontrib><creatorcontrib>Williamson, Toni</creatorcontrib><creatorcontrib>Markham, Anthony</creatorcontrib><title>Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg
−1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg
S-bromo-willardiine injected into the cortex or white matter of 5-day-old mice pups. As the multiple effects of PIT may induce both beneficial and deleterious effects, a reanalysis of the structure–activity relationship was undertaken. PIT (50 μM) and 2,3′-pyridylisatogen were potent antagonists of responses to ATP in the taenia preparation of the guinea-pig caecum, but 2,3′-nitrophenylisatogen was not. The reactive immine oxide group could be substituted by a keto moiety (
N-(2′-pyridyl)phthalide) while maintaining antagonism of responses to ATP, equivalent to PIT. Thus, antagonism of P2Y receptors was not restricted to the isatogen nucleus. Other spin traps did not antagonise P2Y receptors, although dimethyl-pyrroline-
N-oxide (DMPO) increased the sensitivity of responses to ATP. Both
N-(2′-pyridyl)phthalide and 2,3′-nitrophenylisatogen was less neuroprotective than PIT (10 mg kg
−1, i.p.) in protecting against the
S-bromo-willardiine-induced lesions in mice, implying that both antagonism of P2Y receptors and the immine oxide moiety may be important for the neuroprotective effects of PIT. However, the usefulness of the neuroprotection was limited because, in motoneurones obtained from rat embryos, PIT (10–100 μM) exacerbated cell death.</description><subject>2,2′-Pyridylisatogen</subject><subject>AMPA receptor</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>ATP antagonist</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Immine oxide</subject><subject>Isatin - analogs & derivatives</subject><subject>Isatin - pharmacology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Motoneuron</subject><subject>Motor Neurons - drug effects</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth - drug effects</subject><subject>Neuropharmacology</subject><subject>Neuroprotection</subject><subject>Neuroprotective agent</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>P2Y receptor</subject><subject>Pharmacology. Drug treatments</subject><subject>Purinergic P2 Receptor Antagonists</subject><subject>Spin trap</subject><subject>Spin Trapping</subject><subject>Structure-Activity Relationship</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2KFDEUhYMoTjv6CEo2ioKluUlXpbISGfyDAcWfhauQSm61kapKmaQGeufW1_GRfBJT3Y2zdHUv4Ts3h3MIuQ_sGTBonn9iDLYVV0o9ZvwJg7oVFb9BNtBKVTEJ_CbZ_EPOyJ2UvjPGasXr2-QMOKii4Bvy62MYkIaeptlPNEczl7mjZnL0A_9KI1qcc4jlIZtdmHwa6cp9QzrhEsMcQ0ab_RVS7PuypfUWf8r__Pxdzfvo3X7wyeSww6IKaT-YjIfrEdfVURvGOSyTS3fJrd4MCe-d5jn58vrV54u31eX7N-8uXl5WVijIFYJTnQLsABUzttsCdK1C6RzUshe2lRaVkNxJANU2rmn6DlE4ZAbQWSHOyaPj3eL9x4Ip69Eni8NgJgxL0pIzLrcCClgfQRtDShF7PUc_mrjXwPTagT50oNeANeP60IHmRffg9MHSjeiuVafQC_DwBJhkzdBHM1mfrrniXohGFu7FkcMSx5XHqJP1OFl0vvSStQv-P1b-Akfzp1s</recordid><startdate>20020524</startdate><enddate>20020524</enddate><creator>Menton, Kevin</creator><creator>Spedding, Michael</creator><creator>Gressens, Pierre</creator><creator>Villa, Pascal</creator><creator>Williamson, Toni</creator><creator>Markham, Anthony</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020524</creationdate><title>Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds</title><author>Menton, Kevin ; Spedding, Michael ; Gressens, Pierre ; Villa, Pascal ; Williamson, Toni ; Markham, Anthony</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-e1d9b91eb1e90acb411b89e7dd157f3c87ce9372d711986d66fbee3de0a1edc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>2,2′-Pyridylisatogen</topic><topic>AMPA receptor</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>ATP antagonist</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Immine oxide</topic><topic>Isatin - analogs & derivatives</topic><topic>Isatin - pharmacology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Motoneuron</topic><topic>Motor Neurons - drug effects</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth - drug effects</topic><topic>Neuropharmacology</topic><topic>Neuroprotection</topic><topic>Neuroprotective agent</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>P2Y receptor</topic><topic>Pharmacology. Drug treatments</topic><topic>Purinergic P2 Receptor Antagonists</topic><topic>Spin trap</topic><topic>Spin Trapping</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Menton, Kevin</creatorcontrib><creatorcontrib>Spedding, Michael</creatorcontrib><creatorcontrib>Gressens, Pierre</creatorcontrib><creatorcontrib>Villa, Pascal</creatorcontrib><creatorcontrib>Williamson, Toni</creatorcontrib><creatorcontrib>Markham, Anthony</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Menton, Kevin</au><au>Spedding, Michael</au><au>Gressens, Pierre</au><au>Villa, Pascal</au><au>Williamson, Toni</au><au>Markham, Anthony</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2002-05-24</date><risdate>2002</risdate><volume>444</volume><issue>1</issue><spage>53</spage><epage>60</epage><pages>53-60</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg
−1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg
S-bromo-willardiine injected into the cortex or white matter of 5-day-old mice pups. As the multiple effects of PIT may induce both beneficial and deleterious effects, a reanalysis of the structure–activity relationship was undertaken. PIT (50 μM) and 2,3′-pyridylisatogen were potent antagonists of responses to ATP in the taenia preparation of the guinea-pig caecum, but 2,3′-nitrophenylisatogen was not. The reactive immine oxide group could be substituted by a keto moiety (
N-(2′-pyridyl)phthalide) while maintaining antagonism of responses to ATP, equivalent to PIT. Thus, antagonism of P2Y receptors was not restricted to the isatogen nucleus. Other spin traps did not antagonise P2Y receptors, although dimethyl-pyrroline-
N-oxide (DMPO) increased the sensitivity of responses to ATP. Both
N-(2′-pyridyl)phthalide and 2,3′-nitrophenylisatogen was less neuroprotective than PIT (10 mg kg
−1, i.p.) in protecting against the
S-bromo-willardiine-induced lesions in mice, implying that both antagonism of P2Y receptors and the immine oxide moiety may be important for the neuroprotective effects of PIT. However, the usefulness of the neuroprotection was limited because, in motoneurones obtained from rat embryos, PIT (10–100 μM) exacerbated cell death.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>12191582</pmid><doi>10.1016/S0014-2999(02)01583-2</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2002-05, Vol.444 (1), p.53-60 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_72027431 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | 2,2′-Pyridylisatogen AMPA receptor Animals Animals, Newborn ATP antagonist Biological and medical sciences Dose-Response Relationship, Drug Female Guinea Pigs Immine oxide Isatin - analogs & derivatives Isatin - pharmacology Medical sciences Mice Motoneuron Motor Neurons - drug effects Muscle Contraction - drug effects Muscle, Smooth - drug effects Neuropharmacology Neuroprotection Neuroprotective agent Neuroprotective Agents - pharmacology P2Y receptor Pharmacology. Drug treatments Purinergic P2 Receptor Antagonists Spin trap Spin Trapping Structure-Activity Relationship |
title | Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T06%3A11%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20spin%20trapping%20and%20P2Y%20receptor%20antagonism%20in%20the%20neuroprotective%20effects%20of%202,2%E2%80%B2-pyridylisatogen%20tosylate%20and%20related%20compounds&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Menton,%20Kevin&rft.date=2002-05-24&rft.volume=444&rft.issue=1&rft.spage=53&rft.epage=60&rft.pages=53-60&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/S0014-2999(02)01583-2&rft_dat=%3Cproquest_cross%3E72027431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72027431&rft_id=info:pmid/12191582&rft_els_id=S0014299902015832&rfr_iscdi=true |